Antiretroviral Therapy Adherence Among Transgender Women Living With HIV

Jae M. Sevelius, Adam Carrico, Mallory O. Johnson

Research output: Contribution to journalArticlepeer-review

91 Scopus citations


Despite disproportionate rates of HIV among transgender women and evidence that medication adherence is necessary for treatment success and increased likelihood of survival, there has been little investigation into antiretroviral therapy (ART) adherence issues among transgender women. This study examined rates of self-reported ART adherence among transgender women on ART (n = 35) and well-established correlates of nonadherence, including depression, adherence self-efficacy, patient perceptions of interactions with their providers, and perceived adverse side effects of ART compared to other respondents (n = 2,770). Transgender women on ART were less likely to report 90% adherence rates or higher and reported less confidence in their abilities to integrate treatment regimens into their daily lives. When transgender women were compared to other respondents, regardless of the current medication regimen, they reported significantly fewer positive interactions with their health care providers. Training for providers and integration of hormone therapy into HIV care is recommended.

Original languageEnglish (US)
Pages (from-to)256-264
Number of pages9
JournalJournal of the Association of Nurses in AIDS Care
Issue number3
StatePublished - May 2010
Externally publishedYes


  • AIDS
  • HIV
  • adherence
  • antiretroviral therapy
  • transgender
  • women

ASJC Scopus subject areas

  • Advanced and Specialized Nursing


Dive into the research topics of 'Antiretroviral Therapy Adherence Among Transgender Women Living With HIV'. Together they form a unique fingerprint.

Cite this